Parallel Advisors’s Acutus Medical Inc AFIB Stock Holding History

Parallel Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-129	Closed	–	–	3352
2021 Q4	$0	Buy	129 +117	+975%	+$659	﹤0.01%	3353
2021 Q3	$0	Buy	+12	New	+$158	﹤0.01%	3321

Other funds holding AFIB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Parallel Advisors's AFIB Position: Q1 2022 in Review

Parallel Advisors sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 129 shares.

Parallel Advisors first reported a position in AFIB in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

Parallel Advisors reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 129 Acutus Medical Inc shares in Q1 2022.
Parallel Advisors first reported a position in Acutus Medical Inc in Q3 2021 and held it in 2 quarters.
Parallel Advisors's Acutus Medical Inc position peaked at $0 in Q4 2021.
65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.